246 related articles for article (PubMed ID: 17637110)
1. Molecular targets for disrupting leukocyte trafficking during multiple sclerosis.
McCandless EE; Klein RS
Expert Rev Mol Med; 2007 Jul; 9(20):1-19. PubMed ID: 17637110
[TBL] [Abstract][Full Text] [Related]
2. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.
Correale J; Villa A
Autoimmunity; 2007 Mar; 40(2):148-60. PubMed ID: 17453713
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory potential and migratory capacities across human brain endothelial cells of distinct glatiramer acetate-reactive T cells generated in treated multiple sclerosis patients.
Kim HJ; Biernacki K; Prat A; Antel JP; Bar-Or A
Clin Immunol; 2004 Apr; 111(1):38-46. PubMed ID: 15093550
[TBL] [Abstract][Full Text] [Related]
4. Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma.
Archambault AS; Sim J; Gimenez MA; Russell JH
Eur J Immunol; 2005 Apr; 35(4):1076-85. PubMed ID: 15761850
[TBL] [Abstract][Full Text] [Related]
5. Is damage in central nervous system due to inflammation?
Chavarria A; Alcocer-Varela J
Autoimmun Rev; 2004 Jun; 3(4):251-60. PubMed ID: 15246020
[TBL] [Abstract][Full Text] [Related]
6. Determinants of CCL5-driven mononuclear cell migration across the blood-brain barrier. Implications for therapeutically modulating neuroinflammation.
Ubogu EE; Callahan MK; Tucky BH; Ransohoff RM
J Neuroimmunol; 2006 Oct; 179(1-2):132-44. PubMed ID: 16857269
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic targeting of chemokine signaling in Multiple Sclerosis.
Hamann I; Zipp F; Infante-Duarte C
J Neurol Sci; 2008 Nov; 274(1-2):31-8. PubMed ID: 18706659
[TBL] [Abstract][Full Text] [Related]
8. Perivascular spaces and the two steps to neuroinflammation.
Owens T; Bechmann I; Engelhardt B
J Neuropathol Exp Neurol; 2008 Dec; 67(12):1113-21. PubMed ID: 19018243
[TBL] [Abstract][Full Text] [Related]
9. The expression and function of chemokines involved in CNS inflammation.
Ubogu EE; Cossoy MB; Ransohoff RM
Trends Pharmacol Sci; 2006 Jan; 27(1):48-55. PubMed ID: 16310865
[TBL] [Abstract][Full Text] [Related]
10. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
[TBL] [Abstract][Full Text] [Related]
11. Human mesenchymal stem cells target adhesion molecules and receptors involved in T cell extravasation.
Benvenuto F; Voci A; Carminati E; Gualandi F; Mancardi G; Uccelli A; Vergani L
Stem Cell Res Ther; 2015 Dec; 6():245. PubMed ID: 26651832
[TBL] [Abstract][Full Text] [Related]
12. How do immune cells overcome the blood-brain barrier in multiple sclerosis?
Larochelle C; Alvarez JI; Prat A
FEBS Lett; 2011 Dec; 585(23):3770-80. PubMed ID: 21550344
[TBL] [Abstract][Full Text] [Related]
13. [Multiple sclerosis: epidemiology, molecular pathology and therapy].
Steck AJ; Schaeren-Wiemers N
Schweiz Med Wochenschr; 1999 Nov; 129(46):1764-8. PubMed ID: 10603650
[TBL] [Abstract][Full Text] [Related]
14. [Intercellular adhesion molecules and chemotaxic factors in the pathogenesis of multiple sclerosis].
González-Amaro R; Sánchez-Madrid F
Rev Neurol; 2002 Nov 16-30; 35(10):985-93. PubMed ID: 12436404
[TBL] [Abstract][Full Text] [Related]
15. Review: leucocyte-endothelial cell crosstalk at the blood-brain barrier: a prerequisite for successful immune cell entry to the brain.
Greenwood J; Heasman SJ; Alvarez JI; Prat A; Lyck R; Engelhardt B
Neuropathol Appl Neurobiol; 2011 Feb; 37(1):24-39. PubMed ID: 20946472
[TBL] [Abstract][Full Text] [Related]
16. Human mast cells stimulate activated T cells: implications for multiple sclerosis.
Theoharides TC; Kempuraj D; Kourelis T; Manola A
Ann N Y Acad Sci; 2008 Nov; 1144():74-82. PubMed ID: 19076366
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases.
Pedemonte E; Mancardi G; Giunti D; Corcione A; Benvenuto F; Pistoia V; Uccelli A
Pharmacol Ther; 2006 Sep; 111(3):555-66. PubMed ID: 16442633
[TBL] [Abstract][Full Text] [Related]
18. Targeting leukocyte recruitment in the treatment of psoriasis.
Li YY; Zollner TM; Schön MP
Clin Dermatol; 2008; 26(5):527-38. PubMed ID: 18755372
[TBL] [Abstract][Full Text] [Related]
19. Migratory pathways of gammadelta T cells and response to CXCR3 and CXCR4 ligands: adhesion molecules involved and implications for multiple sclerosis pathogenesis.
Poggi A; Zancolli M; Catellani S; Borsellino G; Battistini L; Zocchi MR
Ann N Y Acad Sci; 2007 Jun; 1107():68-78. PubMed ID: 17804534
[TBL] [Abstract][Full Text] [Related]
20. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system.
Cayrol R; Wosik K; Berard JL; Dodelet-Devillers A; Ifergan I; Kebir H; Haqqani AS; Kreymborg K; Krug S; Moumdjian R; Bouthillier A; Becher B; Arbour N; David S; Stanimirovic D; Prat A
Nat Immunol; 2008 Feb; 9(2):137-45. PubMed ID: 18157132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
